Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
mirtazapine (remeron) (1 trial)
Depressive Disorder (Phase 4)
Disease (Phase 4)
Mental Disorders (Phase 4)
Mood Disorders (Phase 4)
Trials (1 total)
Trial APIs (1 total)